Ryusuke Nambu

Pediatric Gastroenterologist, Pediatric IBD Specialist, monogenic IBD @SaitamaChildren'sMedicalCenter, Japan

[Ryusuke Nambu @NambuRyusuke]

@pedsGI_Japan おめでとうございます！

[Ryusuke Nambu @NambuRyusuke]

@pedsGI_Japan 素晴らしい論文！Ericとのpopulatin based reseachですね！

[Ryusuke Nambu @NambuRyusuke]

@pedsGI_Japan おめでとうございます！！

[The Hospital for Sick Children (SickKids) @SickKidsNews]

A breakthrough for Crohn’s disease: Published in @AGA_Gastro, #SKResearch team drives discovery of a new genetic cause of the disease and a biological pathway that could serve as a therapeutic target.

Read more ⬇️ https://t.co/VEV9z7KSui

#IBD #PrecisionChildHealth

[Eric Benchimol @ericbenchimol]

SickKids-led research uncovers new genetic cause of Crohn’s disease, via @EurekAlert! https://t.co/3M78dbs7Yb

[Ryusuke Nambu @NambuRyusuke]

@kotlarz_lab @AGA_Gastro Congratulations, Daniel! Proud to have collaborated with you🍻

[Ryusuke Nambu @NambuRyusuke]

Proud to be part of this incredible collaboration. I hope these findings will advance our understanding of IBD and improve patinet care.

[Aleixo Muise @AleixoMMuise]

BIRC3 (Encoding Cellular Inhibitor of Apoptosis Protein 2) Variants Result in Dysregulated Receptor-Interacting Protein Kinase 1 Signaling Leading to Increased Epithelial Cell Death and Are Associated With Monogenic Crohn’s Disease - Gastroenterology https://t.co/CdCMG31VSg

[Kotlarz Lab @kotlarz_lab]

BIRC3 (Encoding Cellular Inhibitor of Apoptosis Protein 2) Variants Result in Dysregulated Receptor-Interacting Protein Kinase 1 Signaling Leading to Increased Epithelial Cell Death and Are Associated With Monogenic Crohn’s Disease - Gastroenterology @AGA_gastro https://t.co/BPZmzIqSFB

[RareBioGen @rarebiogen]

Discovery of BIRC3 gene variants in Crohn's disease yields a druggable pathway https://t.co/lPITmJ7fOu

[Dr. Yoshi 子どものおなかと栄養の専門医 @pedsGI_Japan]

【ご報告】本を出版します

『こどものおなかの診かた，考えかた』

日本、カナダ、米国の小児施設で培った「こどもの腹部診療」の知見を1冊にまとめました
日米欧のガイドラインを整理し、外来や救急ですぐ使える内容です。現場の先生方のお役に立てれば幸いです

6月下旬出版予定です。ぜひ！

[Ryusuke Nambu @NambuRyusuke]

@pedsGI_Japan おめでとうございます。買います！Amazonポチりました😄

[Ryusuke Nambu @NambuRyusuke]

@pedsGI_Japan おめでとうございます！素晴らしいお仕事です！

[Ryusuke Nambu @NambuRyusuke]

Happy to share! Hope this can help move #VEOIBD treatment strategies forward.
#pediatricibd #IBD

https://t.co/vmuK3Ymlhn

[Ryusuke Nambu @NambuRyusuke]

@pedsGI_Japan 素晴らしいです！おめでとうございます！益々のご活躍を祈っています！

[Eric Topol @EricTopol]

How do mRNA vaccines help fight cancer?
A @nature publication today tells the story, one with big implications, as reviewed here @MDAndersonNews
@StevenLin_MDPhD @adam_grippin
https://t.co/J0OvNP1Oc4

[Gastroenterology @AGA_Gastro]

July's Editor's Essential Reading evaluates capsule endoscopy–guided proactive treat-to-target versus continued standard care in patients with quiescent #CrohnsDisease. Read the full article to learn more➡️ https://t.co/T4iPXZDflK

[Aleixo Muise @AleixoMMuise]

Very excited to share our latest work -demonstrating 50% diagnostic rate for CODE and 3 new CODE genes, MYO1A, GRWD1, and MON1A. @NEJM

The Genetic Architecture of Congenital Diarrhea and Enteropathy | New England Journal of Medicine https://t.co/QC47B03nPb

[Keisuke Honda @kskgroup2017]

日本政府が本当にばら撒くべき人たちは、研究者たちである。良い研究に関する議論は必要やけど、言葉選ばずに言うと、とにかくばら撒け。

[Ryusuke Nambu @NambuRyusuke]

Thanks!

[埼玉県立小児医療センター @scmc_pho]

【日本炎症性腸疾患学会(JSIBD)にて優秀演題として表彰されました】
消化器･肝臓科 南部隆亮医師、服部透也医師の発表がそれぞれ優秀演題として表彰されました。当センターは学会よりIBD指導施設に認定されています。小児IBD診療の発展に貢献して参ります。

#埼玉県立小児医療センター
#炎症性腸疾患

[Michael J Rosen, MD, MSCI @DrRosenIBD]

@AleixoMMuise teaches us that 1 in 20 pediatric #IBD patients @SickKidsNews have monigenic cause of IBD and 10% of published cases of monogenic IBD diagnosed as adults. @SMCH_IBD_Celiac Research Symposium.